Showing 3,521 - 3,540 results of 3,735 for search '"endocrinology"', query time: 0.09s Refine Results
  1. 3521
  2. 3522
  3. 3523

    Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin by Xingyuan Ma, Xingyuan Ma, Chao Sun, Xiao Ding, Yuhang Zhang, Yuhang Zhang, Tingzhen Deng, Tingzhen Deng, Yatao Wang, Yatao Wang, Haijun Yang, Haijun Yang, Ruiwen Ding, Ruiwen Ding, Haotian Li, Haotian Li, Dawen Wang, Dawen Wang, Maohua Zheng, Maohua Zheng

    Published 2025-01-01
    “…Metformin (MET) is a commonly used drug for the treatment of type 2 diabetes in the department of endocrinology. In recent years, due to the few clinically effective treatment options including glioma, some scholars have proposed the possibility of metformin in the treatment of glioma, and studies have shown that metformin has a certain inhibitory effect on this tumor. …”
    Get full text
    Article
  4. 3524
  5. 3525
  6. 3526
  7. 3527
  8. 3528
  9. 3529
  10. 3530
  11. 3531
  12. 3532
  13. 3533
  14. 3534
  15. 3535
  16. 3536
  17. 3537

    Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing by Roldan Munoz S, Mol PGM, de Vries F, van Dijk PR, Hillege H, Postmus D, de Vries ST

    Published 2025-01-01
    “…Sonia Roldan Munoz,1 Peter GM Mol,1 Femke de Vries,2 Peter R van Dijk,3 Hans Hillege,4 Douwe Postmus,4 Sieta T de Vries1 1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; 2Faculty of Beta Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 3Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; 4Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsCorrespondence: Sieta T de Vries, Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, Email s.t.de.vries@umcg.nlBackground: Treatment guidelines recommend metformin as initial drug in many people with type 2 diabetes (T2D) and low risk of cardiovascular disease, with the possibility to switch to or add other drug classes. …”
    Get full text
    Article
  18. 3538
  19. 3539
  20. 3540